Characterisation of fluoroquinolone-resistant clinical isolates of Streptococcus pyogenes in Barcelona, Spain

被引:18
|
作者
Rivera, A
Rebollo, M
Sánchez, F
Navarro, F
Miró, E
Mirelis, B
Coll, P
机构
[1] Hosp Santa Creu & Sant Pau, Microbiol Serv, Barcelona 08025, Spain
[2] Univ Autonoma Barcelona, Dept Genet & Microbiol, Unitat Microbiol, E-08193 Barcelona, Spain
关键词
epidemiology; gyrA; parC; quinolones; resistance; Streptococcus pyogenes;
D O I
10.1111/j.1469-0691.2005.01216.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Resistance mechanisms and clonal relationships were determined for six Streptococcus pyogenes isolates with low- or high-level ciprofloxacin resistance. Four isolates displayed reduced susceptibility to ciprofloxacin and levofloxacin and had alterations in ParC: Ser80 -> Pro (isolate emm3.1); Ser79 -> Ala (two isolates emm6.0); and a double substitution Ser79 -> Phe and Ala121 -> Val (isolate emm12.27). Two isolates (emm12.26) displayed high-level resistance to ciprofloxacin and levofloxacin, as well as to other quinolones. These isolates had the same double substitution in ParC as isolate emm12.27, and an additional substitution (Ser81 -> Tyr) in GyrA. Resistance patterns, emm typing and sequencing of the quinolone resistance-determining regions defined two clusters containing three and two isolates, respectively.
引用
收藏
页码:759 / 761
页数:3
相关论文
共 50 条
  • [41] Cross-resistance among fluoroquinolone resistant clinical isolates of Streptococcus pneumoniae
    Evangelista, A
    Loeloff, M
    Pfleger, S
    Davies, T
    Bush, K
    Mauriz, Y
    Sahm, D
    Goldschmidt, R
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 : 29 - 29
  • [42] Levofloxacin treatment failure in a patient with fluoroquinolone-resistant Streptococcus pneumoniae pneumonia
    Kays, MB
    Smith, DW
    Wack, MF
    Denys, GA
    PHARMACOTHERAPY, 2002, 22 (03): : 395 - 399
  • [43] High Prevalence of Cross-Resistance to Aminoglycosides in Fluoroquinolone-Resistant Escherichia coli Clinical Isolates
    Tsukamoto, Naoyuki
    Ohkoshi, Yasuo
    Okubo, Torahiko
    Sato, Toyotaka
    Kuwahara, Osamu
    Fujii, Nobuhiro
    Tamura, Yutaka
    Yokot, Shin-ichi
    CHEMOTHERAPY, 2013, 59 (05) : 379 - 384
  • [44] Characterization of gyrA, gyrB, grlA and grlB mutations in fluoroquinolone-resistant clinical isolates of Staphylococcus aureus
    Takahashi, H
    Kikuchi, T
    Shoji, S
    Fujimura, S
    Lutfor, AB
    Tokue, Y
    Nukiwa, T
    Watanabe, A
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (01) : 49 - 57
  • [45] Phylogenetic background and virulence profiles of fluoroquinolone-resistant clinical Escherichia coli isolates from The Netherlands
    Johnson, JR
    van der Schee, C
    Kuskowski, MA
    Goessens, W
    van Belkum, A
    JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (12): : 1852 - 1856
  • [46] Emergence of erythromycin-resistant, clindamycin-susceptible Streptococcus pyogenes isolates in Madrid, Spain
    Garcia-Bermejo, I
    Cacho, J
    Orden, B
    Alós, JI
    Gómez-Garcés, JL
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (04) : 989 - 990
  • [47] Characteristics of Fluoroquinolone-Resistant of Avian Pathogenic Escherichia coli Isolates in China
    Liu, Xiaowen
    Wang, Yanhong
    Wang, Xiaoquan
    JOURNAL OF ANIMAL AND VETERINARY ADVANCES, 2012, 11 (23): : 4406 - 4412
  • [48] Prevalence and Molecular Characterization of Fluoroquinolone-Resistant Mycobacterium tuberculosis Isolates in China
    Zhang, Zhijian
    Lu, Jie
    Wang, Yufeng
    Pang, Yu
    Zhao, Yanlin
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (01) : 364 - 369
  • [49] Multiple resistance mechanisms in fluoroquinolone-resistant Salmonella isolates from Germany
    Guerra, B
    Malorny, B
    Schroeter, A
    Helmuth, R
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (06) : 2059 - 2059
  • [50] Prevalence and characteristics of fluoroquinolone-resistant Aerococcus urinae isolates detected in Switzerland
    Guilarte, Yuvia Naomi
    Tinguely, Regula
    Lupo, Agnese
    Endimiani, Andrea
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2014, 43 (05) : 474 - 475